Your browser doesn't support javascript.
loading
Silencing of ARHGAP21, a Rho GTPase activating protein (RhoGAP), reduces the growth of prostate cancer xenografts in NOD/SCID mice.
Lazarini, Mariana; Assis-Mendonça, Guilherme Rossi; Machado-Neto, João Agostinho; Latuf-Filho, Paulo; Bezerra, Stephania Martins; Vieira, Karla Priscila; Saad, Sara Teresinha Olalla.
Affiliation
  • Lazarini M; Department of Pharmaceutical Sciences, Federal University of Sao Paulo, Diadema, Sao Paulo, Brazil; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Sao Paulo, Brazil. Electronic address: lazarini@unifesp.br.
  • Assis-Mendonça GR; Department of Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil.
  • Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences of the University of São Paulo, São Paulo, Brazil.
  • Latuf-Filho P; Center for Investigation in Pediatrics (Ciped), Campinas, São Paulo, Brazil.
  • Bezerra SM; Department of Pathology, AC Camargo Cancer Center, São Paulo, Brazil.
  • Vieira KP; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Sao Paulo, Brazil.
  • Saad STO; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Sao Paulo, Brazil.
Biochim Biophys Acta Mol Cell Res ; 1870(4): 119439, 2023 04.
Article in En | MEDLINE | ID: mdl-36764390

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / GTPase-Activating Proteins Limits: Animals / Humans / Male Language: En Journal: Biochim Biophys Acta Mol Cell Res Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / GTPase-Activating Proteins Limits: Animals / Humans / Male Language: En Journal: Biochim Biophys Acta Mol Cell Res Year: 2023 Document type: Article
...